Emergent BioSolutions Inc.

US$6.06As of Sun 8 Nov 2026, 12:00 UTC
NYSE:EBSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (13.76%)
Div yield —
ROE (58.21%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 2.37
PE TTM —
TSR TTM (51.44%)
Mkt cap US$311.6M
ROIC 5.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.89
(2.86%)
(47.85%)
Hold 7|8|7|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.07
10.93%
1.41%
15.03%
11.69%
Revenue$M
30.97
32.69
33.89
33.90
2.30%
10.02%
12.36%
12.51%
Peers (US$311.6M)
Cap (US$)
PE
245.4M
—
Capital
TTM
5Y
10Y
Leveragex
3.516
(0.147)
(0.136)
EBIT/Intx
0.819
0.860
0.786
Own earn%
(44.84)
(240.61)
(183.50)
Sh yield%
24.99
15.85
17.49
Owners
Insiders/Inst%
11.18
76.31
Short interest%
2.15
SBC / revenue%
1.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
13–24
$1 testx
0.2
Incr. ROIC%
13